Skip to main navigation

Investors
News & Media
- News
Healthcare Professionals
Careers

Search for:

Global
Canada
- EN
- FR

Search for:

About
About

Acadia is trailblazing breakthroughs in neuroscience to elevate life. For more than 25 years, we have been working at the forefront of healthcare to bring vital solutions to people who need them most.
Learn More
Our Medicines

Our Medicines

Learn more about our FDA-approved treatments.

NUPLAZID® (pimavanserin)

DAYBUE™ (trofinetide)
Pipeline

Pipeline

We are driven to develop innovative and novel medicines to help address unmet medical needs and to elevate life through science.

Product Pipeline

Clinical Trials
Therapeutic Areas
Therapeutic Areas

At Acadia, we see promise in therapeutic areas where the unmet need remains high.
Learn More
Patients
Perspectives

About
Back
About
Our Medicines

Back

Our Medicines
Pipeline

Back

Pipeline
Therapeutic Areas
Back
Therapeutic Areas
Patients
Perspectives
Investors
Back
Investors
News & Media
Back
News & Media
- News
Healthcare Professionals
Careers
Back
Careers

Investors › financial information

Financial Information

Stock
- Stock Information
- Analyst Coverage
News & Events
- News Releases
- Events & Presentations
Financials
- SEC Filings
- Annual Report and Proxy
Governance
Resources
- Email Alerts
- Information Request

Financial Information

Show all

2024

Q3

Acadia Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operating Overview

Q2

Acadia Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operating Overview
Form 10-Q

Q1

Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview
10-Q Quarterly report which provides a continuing view of a company's financial position

2023

Q4

Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating Overview
10-K Annual report which provides a comprehensive overview of the company for the past year

Q3

Acadia Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operating Overview
10-Q Quarterly report which provides a continuing view of a company's financial position

Q2

Acadia Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operating Overview
10-Q Quarterly report which provides a continuing view of a company's financial position

Q1

Acadia Pharmaceuticals Reports First Quarter 2023 Financial Results and Operating Overview
10-Q Quarterly report which provides a continuing view of a company's financial position

2022

Q4

Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operating Overview
10-K Annual report which provides a comprehensive overview of the company for the past year

Q3

Acadia Pharmaceuticals Reports Third Quarter 2022 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

Q2

Acadia Pharmaceuticals Reports Second Quarter 2022 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

Q1

Acadia Pharmaceuticals Reports First Quarter 2022 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

2021

Q4

Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
10-K Annual report which provides a comprehensive overview of the company for the past year

Q3

Acadia Pharmaceuticals Reports Third Quarter 2021 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

Q2

Acadia Pharmaceuticals Reports Second Quarter 2021 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

Q1

Acadia Pharmaceuticals Reports First Quarter 2021 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

2020

Q4

Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
10-K Annual report which provides a comprehensive overview of the company for the past year

Q3

Acadia Pharmaceuticals Reports Third Quarter 2020 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

Q2

ACADIA Pharmaceuticals Reports Second Quarter 2020 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

Q1

ACADIA Pharmaceuticals Reports First Quarter 2020 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

2019

Q4

ACADIA Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
10-K Annual report which provides a comprehensive overview of the company for the past year

Q3

ACADIA Pharmaceuticals Reports Third Quarter 2019 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

Q2

ACADIA Pharmaceuticals Reports Second Quarter 2019 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

Q1

ACADIA Pharmaceuticals Reports First Quarter 2019 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

2018

Q4

ACADIA Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
10-K Annual report which provides a comprehensive overview of the company for the past year

Q3

ACADIA Pharmaceuticals Reports Third Quarter 2018 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

Q2

ACADIA Pharmaceuticals to Announce Second Quarter 2018 Financial Results on August 8, 2018

ACADIA Pharmaceuticals Reports Second Quarter 2018 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

Q1

ACADIA Pharmaceuticals Reports First Quarter 2018 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

2017

Q4

ACADIA Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
10-K Annual report which provides a comprehensive overview of the company for the past year

Q3

ACADIA Pharmaceuticals Reports Third Quarter 2017 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

Q2

ACADIA Pharmaceuticals Reports Second Quarter 2017 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

Q1

ACADIA Pharmaceuticals Reports First Quarter 2017 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

2016

Q4

ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016
10-K Annual report which provides a comprehensive overview of the company for the past year

Q3

ACADIA Pharmaceuticals Reports Third Quarter 2016 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

Q2

ACADIA Pharmaceuticals Reports Second Quarter 2016 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

Q1

ACADIA Pharmaceuticals Reports First Quarter 2016 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

2015

Q4

ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015
10-K Annual report which provides a comprehensive overview of the company for the past year

Q3

ACADIA Pharmaceuticals Reports Third Quarter 2015 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

Q2

ACADIA Pharmaceuticals Reports Second Quarter 2015 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

Q1

ACADIA Pharmaceuticals Reports First Quarter 2015 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

2014

Q4

ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2014
10-K Annual report which provides a comprehensive overview of the company for the past year

Q3

ACADIA Pharmaceuticals Reports Third Quarter 2014 Financial Results and Updates Timing of NUPLAZID™ NDA Submission
10-Q Quarterly report which provides a continuing view of a company's financial position

Q2

ACADIA Pharmaceuticals Reports Second Quarter 2014 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

Q1

ACADIA Pharmaceuticals Reports First Quarter 2014 Financial Results
10-Q Quarterly report which provides a continuing view of a company's financial position

2013

Q4

ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2013
10-K Annual report which provides a comprehensive overview of the company for the past year

Investors Contact

Click here to contact Investor Relations.

Investor Contact

Email Alerts

Click here to sign up for email alerts.

© 2024 Acadia Pharmaceuticals Inc.
All rights reserved.

Privacy Policy
Data Privacy Framework Notice
Compliance Policy
Accessibility
Community Guidelines
Contact Us

LinkedIn
Twitter

Sitemap
Terms of Use
Cookies Policy
Consumer Health Data Privacy Policy
Cookies Settings

This website uses cookies to improve and customize your experience on our website. By using this website without changing your cookie settings in your browser, you agree to our use of cookies. For further details on cookies, how we use cookies and how to delete or block the use of cookies, please read our Cookie Policy.